According to Kaiser Health News (KHN),1 the COVID-19 pandemic has been a real boon to Pfizer. Not only has it yielded “outsize benefits” in terms of profits, but it has also “given the drugmaker unusual weight in determining U.S. health policy.” “Based on internal research, the company’s executives have frequently announced the next stage in… Read More: How Pfizer Profited From the Pandemic »
The new research, in partnership with IABM, found that while the number of companies making low level investments was still higher than pre-pandemic levels, mid-range and high levels of investment are on the rise Tuesday 24th May, Oslo, Norway — Appear, the global leader in media processing and delivery technology, has launched its latest 360°… Read More: Consumer experience takes centre stage as sports broadcasters’ investment budgets… »
For nearly a year, experts have noted that the COVID shots cannot establish herd immunity to end the pandemic, as the gene transfer injections do not prevent infection or transmission. It’s not rocket science, yet health officials and government leaders around the world have irrationally claimed otherwise, and censored any and all — regardless of… Read More: Are We at the End of the Pandemic? »
When we say the word “pharmacy,” we might picture the Main Street brick-and-mortar chain drugstore that dispenses medicines from behind the counter in the far back of the building, and sweet and salty snacks at the front by the cashier. In fact, “pharmacy” is the jumping off point for the expanding and increasingly beloved retail… Read More: Pharmacies Garner Retail Health Love in the Pandemic – Update… »